Therapeutic Potential of Amino Acids in Inflammatory Bowel Disease
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Inflammatory bowel disease (IBD), which includes both ulcerative colitis and Crohn’s disease, is a chronic relapsing inflammation of the gastrointestinal tract, and is difficult to treat. The pathophysiology of IBD is multifactorial and not completely understood, but genetic components, dysregulated immune responses, oxidative stress, and inflammatory mediators are known to be involved. Animal models of IBD can be chemically induced, and are used to study etiology and to evaluate potential treatments of IBD. Currently available IBD treatments can decrease the duration of active disease but because of their adverse effects, the search for novel therapeutic strategies that can restore intestinal homeostasis continues. This review summarizes and discusses what is currently known of the effects of amino acids on the reduction of inflammation, oxidative stress, and cell death in the gut when IBD is present. Recent studies in animal models have identified dietary amino acids that improve IBD, but amino acid supplementation may not be adequate to replace conventional therapy. The animal models used in dietary amino acid research in IBD are described.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chemically induced mouse models of acute and chronic intestinal inflammation
Wirtz, S., Popp, V., Kindermann, M., Gerlach, K., Weigmann, B., Fichtner-Feigl, S., & Neurath, M. F. (2017) · Nature Protocols · doi:10.1038/nprot.2017.044 · Cited by 1,575 · cited 3×
“, in terms of genetics, environmental factors, dysbiosis, inflammatory response or disturbed permeability in human IBD [56].”
BackgroundInfluentialFADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation
Welz, P.-S., Wullaert, A., Vlantis, K., Kondylis, V., Fernández-Majada, V., Ermolaeva, M., Kirsch, P., Sterner-Kock, A., van Loo, G., & Pasparakis, M. (2011) · Nature · doi:10.1038/nature10273 · Cited by 594 · cited 1×
“Intestinal inflammation resulting from increased cell death has been reported to occur in IBD [34,36,38].”
BackgroundMonitoring tryptophan metabolism in chronic immune activation
Schröcksnadel, K., Wirleitner, B., Winkler, C., & Fuchs, D. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.06.013 · Cited by 551
Tapiero, H., Mathé, G., Couvreur, P., & Tew, K. D. (2002) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(02)00285-8 · Cited by 369
Cited by
Oxidative Stress and Redox-Modulating Therapeutics in Inflammatory Bowel Disease
Bourgonje, A. R., Feelisch, M., Faber, K. N., Pasch, A., Dijkstra, G., & van Goor, H. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.06.006 · Cited by 390
Wang, Y., Chen, Y., Zhang, X., Lu, Y., & Chen, H. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104248 · Cited by 262
Gut-origin sepsis in the critically ill patient: pathophysiology and treatment
Assimakopoulos, S. F., Triantos, C., Thomopoulos, K., Fligou, F., Maroulis, I., Marangos, M., & Gogos, C. A. (2018) · Infection · doi:10.1007/s15010-018-1178-5 · Cited by 244
Vidal-Lletjós, S., Andriamihaja, M., Blais, A., Grauso, M., Lepage, P., Davila, A.-M., Viel, R., Gaudichon, C., Leclerc, M., Blachier, F., et al. (2019) · Nutrients · doi:10.3390/nu11030514 · Cited by 42
Herrera, M., & Byerley, L. O. (2025) · Nutrients · doi:10.3390/nu17142373 · Cited by 15
Metadata
- Authors
- Liu, Y., Wang, X., & Hu, C.-A.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2017-08-23
- Volume
- 9
- Issue
- 9
- Pages
- 920
- ISSN
- 2072-6643 (ISSN-L)
- OpenAlex
- W2748192442
- Cited by
- 150
- References
- 4
- FWCI
- 8.18
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.